Bioline Rx Ltd - ADR

NASDAQ:BLRX 12:59:46 AM EDT

4.49

-0.12 (-2.60%)

4:24:00 PM EDT: $4.51 +0.02 (+0.45%)

Market Cap (Intraday)	19.14M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.66 Million
Adjusted EPS	-$0.35

See more estimates

10-Day MA	$4.53
50-Day MA	$4.02
200-Day MA	$8.63

See more pivots

Bioline Rx Ltd - ADR Stock, NASDAQ:BLRX

Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in, HaMerkaz 7177871

Israel

Phone: +972.8.642.9100

Number of Employees: 38

http://www.biolinerx.com

Description

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.